Replies to post #105308 on Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

Having Jim Greenwood as a panelist at "C4CT" is very "significant" news.

It wouldn't surprise me if the share price opens above .15 tomorrow and moves back towards .18 from there.

The word is definitely getting out to the industry and the market that $AMBS is "for real" and has tremendous upside.

LymPro news and a partnership should take the share price to the .25 range and trend up from there to the up-listing.

Interesting weeks and months ahead.

Twitter: @AmarantusBio .... 10,000+ followers.

p.s. I can't understand why anyone is selling here and giving away profits.